Medifast Inc Stock Fundamentals
| MED Stock | USD 33.57 0.15 0.45% |
MEDIFAST INC fundamentals help investors to digest information that contributes to MEDIFAST INC's financial success or failures. It also enables traders to predict the movement of MEDIFAST Stock. The fundamental analysis module provides a way to measure MEDIFAST INC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MEDIFAST INC stock.
At present, MEDIFAST INC's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 753.6 M, whereas Extraordinary Items is projected to grow to (364.2 K). MEDIFAST | Select Account or Indicator |
MEDIFAST INC Company Return On Asset Analysis
MEDIFAST INC's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current MEDIFAST INC Return On Asset | 0.25 |
Most of MEDIFAST INC's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MEDIFAST INC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
MEDIFAST Total Assets
Total Assets |
|
Based on the latest financial disclosure, MEDIFAST INC has a Return On Asset of 0.2524. This is 76.84% lower than that of the Personal Care Products sector and 91.41% lower than that of the Consumer Staples industry. The return on asset for all United States stocks is notably lower than that of the firm.
MEDIFAST INC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MEDIFAST INC's current stock value. Our valuation model uses many indicators to compare MEDIFAST INC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MEDIFAST INC competition to find correlations between indicators driving MEDIFAST INC's intrinsic value. More Info.MEDIFAST INC is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for MEDIFAST INC is roughly 2.21 . At present, MEDIFAST INC's Return On Equity is projected to increase slightly based on the last few years of reporting.Comparative valuation analysis is a catch-all model that can be used if you cannot value MEDIFAST INC by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for MEDIFAST INC's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MEDIFAST INC's earnings, one of the primary drivers of an investment's value.MEDIFAST Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MEDIFAST INC's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MEDIFAST INC could also be used in its relative valuation, which is a method of valuing MEDIFAST INC by comparing valuation metrics of similar companies.MEDIFAST INC is currently under evaluation in return on asset category among related companies.
MEDIFAST Fundamentals
| Return On Equity | 0.56 | ||||
| Return On Asset | 0.25 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 223.45 M | ||||
| Shares Outstanding | 10.9 M | ||||
| Shares Owned By Insiders | 2.70 % | ||||
| Shares Owned By Institutions | 97.75 % | ||||
| Number Of Shares Shorted | 2.66 M | ||||
| Price To Earning | 13.99 X | ||||
| Price To Book | 1.70 X | ||||
| Price To Sales | 0.32 X | ||||
| Revenue | 1.07 B | ||||
| Gross Profit | 1.14 B | ||||
| EBITDA | 139.51 M | ||||
| Net Income | 99.42 M | ||||
| Cash And Equivalents | 87.69 M | ||||
| Cash Per Share | 5.57 X | ||||
| Total Debt | 22.01 M | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 1.29 X | ||||
| Book Value Per Share | 18.69 X | ||||
| Cash Flow From Operations | 147.66 M | ||||
| Short Ratio | 5.83 X | ||||
| Earnings Per Share | 9.10 X | ||||
| Price To Earnings To Growth | 1.95 X | ||||
| Target Price | 37.5 | ||||
| Number Of Employees | 634 | ||||
| Beta | 1.15 | ||||
| Market Capitalization | 364.13 M | ||||
| Total Asset | 309.91 M | ||||
| Retained Earnings | 174.65 M | ||||
| Working Capital | 131.73 M | ||||
| Current Asset | 88.07 M | ||||
| Current Liabilities | 23.56 M | ||||
| Annual Yield | 0.20 % | ||||
| Five Year Return | 2.53 % | ||||
| Net Asset | 309.91 M | ||||
| Last Dividend Paid | 4.95 |
About MEDIFAST INC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MEDIFAST INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEDIFAST INC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEDIFAST INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 574 K | 545.3 K | |
| Total Revenue | 1.1 B | 1.1 B | |
| Cost Of Revenue | 296.2 M | 311 M | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.60 | 0.66 | |
| Research And Ddevelopement To Revenue | 0 | 0 | |
| Capex To Revenue | (0.01) | (0.01) | |
| Revenue Per Share | 98.50 | 103.42 | |
| Ebit Per Revenue | 0.12 | 0.12 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out MEDIFAST INC Piotroski F Score and MEDIFAST INC Altman Z Score analysis. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 4.95 | Earnings Share 9.1 | Revenue Per Share 98.498 | Quarterly Revenue Growth (0.43) |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.